Renewable Design for Idoxuridine - 3-Amino-1-Adamantanol CAS 702-82-9 Vildagliptin Intermediate – Ruifu
Renewable Design for Idoxuridine - 3-Amino-1-Adamantanol CAS 702-82-9 Vildagliptin Intermediate – Ruifu Detail:
Manufacturer with High Purity and Competitive Price
Supply Vildagliptin and Related Intermediates:
Vildagliptin CAS: 274901-16-5
3-Amino-1-hydroxyadamantane CAS: 702-82-9
L-Prolinamide CAS: 7531-52-4
Boc-L-Proline CAS: 15761-39-4
(2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile CAS: 207557-35-5
Chemical Name | 3-Amino-1-Adamantanol |
Synonyms | 1-Amino-3-Hydroxyadamantane; 3-Amino-1-Hydroxyadamantane |
CAS Number | 702-82-9 |
CAT Number | RF-PI102 |
Stock Status | In Stock, Production Scale Up to Tons |
Molecular Formula | C10H17NO |
Molecular Weight | 167.25 |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | White Crystalline Powder |
Purity / Analysis Method | ≥98.5% (HPLC) (dry basis) |
Moisture (K.F) | ≤0.50% |
Residue on Ignition | ≤0.50% |
Melting Point | 266.5℃~272.5℃ |
Test Standard | Enterprise Standard |
Usage | Intermediate of Vildagliptin (CAS: 274901-16-5) |
Package: Bottle, Aluminium foil bag, Cardboard Drum, 25kg/Drum, or according to customer’s requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 3-Amino-1-adamantanol (CAS: 702-82-9) with high quality. Vildagliptin is synthesised from 3-Amino-1-adamantanol.
Vildagliptin is an oral anti-hyperglycemic agent (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Vildagliptin inhibits the inactivation of GLP-1 and GIP by DPP-4, allowing GLP-1 and GIP to potentiate the secretion of insulin in the beta cells and suppress glucagon release by the alpha cells of the islets of Langerhans in the pancreas. Vildagliptin has been shown to reduce hyperglycemia in type 2 diabetes mellitus. Novartis has since withdrawn its intent to submit vildagliptin to the FDA, as of July 2008. It was approved in Feb 2008 by European Medicines Agency for use within the EU and is listed on the Australian PBS with certain restrictions.
Product detail pictures:
Related Product Guide:
Assume full accountability to fulfill all demands of our purchasers; attain continual advancements by marketing the advancement of our clientele; grow to be the final permanent cooperative partner of purchasers and maximize the interests of purchasers for Renewable Design for Idoxuridine - 3-Amino-1-Adamantanol CAS 702-82-9 Vildagliptin Intermediate – Ruifu , The product will supply to all over the world, such as: Curacao, India, Muscat, Taking the core concept of "to be the Responsible". We will redound up on society for high quality products and good service. We will initiative to participate in international competition to be a first- class manufacturer of this product in the world.
By Evangeline from Berlin - 2018.10.31 10:02
The customer service reprersentative explained very detailed, service attitude is very good, reply is very timely and comprehensive, a happy communication! We hope to have a opportunity to cooperate.
By Klemen Hrovat from Angola - 2018.06.19 10:42